Bookmark

Add to MyYahoo RSS

Eli Lilly News

News on Eli Lilly (Ticker: LLY) continually updated from thousands of sources around the net.

2 hrs ago | AmericanBankingNews.com

Eli Lilly and Given New $60.00 Price Target at Morgan Stanley

Morgan Stanley's price objective would suggest a potential downside of 1.12% from the stock's previous close.

Comment?

Related Topix: Alnara Pharmaceuticals, Biotech, Food, Medicine, Avid Radiopharmaceuticals, Agriculture, International Multifoods Corporation, Imclone Systems, Healthcare Industry, Eli Lilly

5 hrs ago | Sys-Con Media

FDA approves JardianceA (empagliflozin) tablets for adults with type 2 diabetes

JARDIANCE is not for people with type 1 diabetes or for people with diabetic ketoacidosis .

Comment?

Related Topix: Medicine, Diabetes, Health, Food and Drug Administration, Biotech, Healthcare Industry, Fasting, Insulin (generic), Humulin, Novolin

14 hrs ago | Sunherald.com

FDA approves Lilly, Boehringer diabetes drug

Federal regulators have approved a new treatment from U.S. drugmaker Eli Lilly and Co.

Comment?

Related Topix: Medicine, Diabetes, Health, Food and Drug Administration, Biotech, Healthcare Industry, Insulin (generic), Humulin, Novolin

18 hrs ago | BioSpace

Ex-Eli Lilly and Company Scientists Fighting Fraud Charges Now Battle ...

Eli Lilly is locked in a battle over the release of hundreds of thousands of pages of internal documents with two of its former scientists, who were charged earlier this year with wire fraud for allegedly leaking proprietary information about experimental drugs and providing the data to a Chinese drug maker.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Thu Jul 31, 2014

Sys-Con Media

The Global and China Insulin Market is Expected to Grow at a CAGR of...

MarketResearchreports.biz presents this most up-to-date research on Global and China Insulin Market - Industry Analysis, Size, Share, Growth, Trends and Forecast , 2013 - 2019: Market Size, Trends, and Forecasts Research Report.

Comment?

Related Topix: Insulin (generic), Humulin, Novolin, Diabetes, Health, Biotech, Healthcare Industry

Wed Jul 30, 2014

AmericanBankingNews.com

Insider Selling: Eli Lilly and major shareholder Sells 250,000 Shares of Stock

Eli Lilly and major shareholder Lilly Endowment Inc sold 250,000 shares of Eli Lilly and stock in a transaction dated Tuesday, July 29th.

Comment?

Related Topix: Alnara Pharmaceuticals, Biotech, Food, Medicine, Avid Radiopharmaceuticals, Agriculture, International Multifoods Corporation, Imclone Systems, Healthcare Industry, Eli Lilly

JD Supra

Court Report -- Part II - July 2014 #2

Acorda Therapeutics Inc. v. Actavis Laboratories FL Inc. 1:14-cv-00882; filed July 7, 2014 in the District Court of Delaware Infringement of U.S. Patent Nos.

Comment?

Related Topix: Biotech, Medicine, Acorda Therapeutics, Healthcare Industry, Insulin (generic), Humulin, Novolin, Lantus, Insulin Glargine (generic), Diabetes, Health, Dr Reddys Laboratories

Seeking Alpha

Ligand: Pipeline Breakdown Reveals Bullish Outlook

With more than 90 shots on goal and several revenue driving opportunities in 2014 alone, investors should watch it very closely.

Comment?

Related Topix: Pharmaceuticals, Biotech, Ligand Pharmaceuticals, Medicine, Healthcare Industry, Amgen

Tue Jul 29, 2014

The Indianapolis Star

Lilly fighting subpoena seeking internal documents

Lilly fighting subpoena seeking internal documents Former Lilly scientists seeking info in their defense against charges they leaked company secrets Check out this story on IndyStar.com: http://indy.st/1mZ9QKw Eli Lilly and Co.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

BioSpace

Big Pharmas Such As Eli Lilly and Company, Johnson & Johnson, Pfizer...

Accelerator Corporation Secures $51.1 Million to Support Emerging Biotechnology Research Opportunities in New York City and Seattle Accelerator IV to Bridge Funding Gap for Early Research;Includes New Strategic Investors Eli Lilly and Company, Harris & Harris Group, Inc., Johnson & Johnson Development Corporation, The Partnership Fund for New York ... (more)

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, New York, Venture Capital, Emerging Technology

Mon Jul 28, 2014

Wall Street Journal

Wanted: Startups in Biotech

The East Side towers of the Alexandria Center for Life Science have attracted giant pharmaceutical companies such as Pfizer Inc. and Eli Lilly & Co.

Comment?

Related Topix: Biotech, Science / Technology, Pfizer, Medicine, Healthcare Industry, Opinion

The San Diego Union-Tribune

NewsUCSD raises $1.1 billion for research

UC San Diego raised almost $1.1 billion for research over the past year, maintaining the school's standing as one of the nation's 10 largest centers for science, engineering and medicine.

Comment?

Related Topix: UC San Diego, Biotech, Medicine, Healthcare Industry, Alzheimer's, Health

Seeking Alpha

Expect Gilead Sciences To Outperform

Based on comparable valuations for the industry, the stock is considerably undervalued.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Eli Lilly, Hepatitis

Sat Jul 26, 2014

AmericanBankingNews.com

Eli Lilly and Receives Neutral Rating from Zacks

's stock had its "neutral" rating restated by Zacks in a report released on Friday.

Comment?

Related Topix: Alnara Pharmaceuticals, Biotech, Food, Medicine, Avid Radiopharmaceuticals, Agriculture, International Multifoods Corporation, Imclone Systems, Healthcare Industry, Eli Lilly

Fri Jul 25, 2014

Schools Matter

Behning's Corporate School Money Still Flowing

Pass this article on to your neighbors, your community members and leaders and to the people in Lockhart's district, many of them in Indianapolis.

Comment?

Related Topix: Household Products, Amway, Biotech, Medicine, Healthcare Industry, Eli Lilly

The Miami Herald

Lilly 2Q profit falls 39 percent

Eli Lilly and Co. on Thursday reported profit that declined by 39 percent in its second quarter, and beat analysts' expectations.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Seeking Alpha

Eli Lilly's (LLY) CEO John Lechleiter on Q2 2014 Results - Earnings Call Transcript

Ladies and gentlemen, thank you for standing by. Welcome to the Q 2014 earnings call.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Eli Lilly, Oncology, Diabetes, Health, Pancreatic Cancer

Thu Jul 24, 2014

Daily Reporter

Covance deal not that simple

While city officials are supportive of drawing roughly 360 acres of the Covance campus into city limits, it's still unclear how tax breaks on the deal would work.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

BioSpace

Eli Lilly and Company Reports Second-Quarter 2014 Results

Second-quarter 2014 revenue declined 17 percent driven by the impact of U.S. patent expirations for Cymbalta and Evista, partially offset by volume growth in several other products.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pancreatic Cancer, Health, Marketing, Healthcare Law, Law, Food and Drug Administration, Diabetes

Insider Monkey

Loss of Patents Main Cause of Lower Earnings at Eli Lilly and Co

The loss of Patents over the years, has been the main cause of lower earnings at Eli Lilly and Co , the CEO of the company, Dr. John Lechleiter, said in an interview on CNBC .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••